An Exploratory, Randomized, Double-Blind, Parallel-Group Controlled Trial to Evaluate the Safety of L-Aspartate Sodium and L-Cystine Intake in Healthy Adults (AJI-2026AC)

未提供0 个研究点目标入组 200 人开始时间: 待定

研究概览

暂无简介。

•Healthy male subjects aged >=20 and <60 years at the time of informed consent
•Subjects who have received a full explanation of the study, have fully understood its purpose and procedures, and have provided written informed consent of their own free will

•Subjects who are continuously taking medications during the intake period of the test food, or who are expected to take such medications
•Subjects who are currently taking, or plan to take, supplements containing amino acids as the main component from the time of study participation until the end of the test food intake period
•Subjects who are currently participating in another clinical study, who have participated in another study within 4 weeks prior to enrollment, or who plan to participate in another study during the study period
•Subjects who meet any of the following criteria:
•1 Subjects with diseases of the heart, liver, or kidneys (including those secondary to other diseases)
•2 Subjects with respiratory diseases
•3 Subjects with a history of cardiovascular disease
•4 Subjects with diabetes mellitus
•5 Subjects with gastrointestinal diseases
•6 Subjects who are currently undergoing treatment for, or have a history of, serious diseases such as cancer or tuberculosis
•Subjects with allergies to medications or foods
•Subjects who are otherwise considered inappropriate for participation in the study by the principal investigator

发起方

未提供